Effects of Donepezil on Cortical Activation in Mild Cognitive Impairment: A Pilot Double-Blind Placebo-Controlled Trial Using Functional MR Imaging

References

1. ↵
   Drzezga A. Concept of functional imaging of memory decline in Alzheimer's disease. Methods 2008;44:304–14

   CrossRefPubMedWeb of Science
2. Ries ML, Carlsson CM, Rowley HA, et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008;56:920–34

   CrossRefPubMedWeb of Science
3. Krishnan S, Talley BD, Slavin MJ, et al. Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. Neuroimaging Clin N Am 2005;15:853–68

   CrossRefPubMed
4. Saykin AJ, Wishart HA. Mild cognitive impairment: conceptual issues and structural and functional brain correlates. Semin Clin Neuropsychiatry 2003;8:12–30

   CrossRefPubMed
5. ↵
   Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315–36

   PubMedWeb of Science
6. ↵
   Dickerson BC, Sperling RA. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx 2005;2:348–60

   Abstract/FREE Full Text
7. ↵
   Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379–88

   CrossRefPubMedWeb of Science
8. ↵
   Salloway S, Ferris S, Kluger A, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004;63:651–57

   Abstract/FREE Full Text
9. ↵
   Venneri A. Imaging treatment effects in Alzheimer's disease. Magn Reson Imaging 2007;25:953–68

   CrossRefPubMedWeb of Science
10. ↵
    Petrella JR, Lustig C, Bucher LA, et al. Prefrontal activation patterns in subjects at risk for Alzheimer disease. Am J Geriatr Psychiatry 2002;10:112–13

    CrossRefPubMed
11. ↵
    Petrella JR, Townsend BA, Jha AP, et al. Increasing memory load modulates regional brain activity in older adults as measured by fMRI. J Neuropsychiatry Clin Neurosci 2005;17:75–83

    PubMedWeb of Science
12. ↵
    Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000;12:1–47

    CrossRefPubMedWeb of Science
13. Prince SE, Daselaar SM, Cabeza R. Neural correlates of relational memory: successful encoding and retrieval of semantic and perceptual associations. J Neurosci 2005;25:1203–10

    Abstract/FREE Full Text
14. Prince SE, Tsukiura T, Cabeza R. Distinguishing the neural correlates of episodic memory encoding and semantic memory retrieval. Psychol Sci 2007;18:144–51

    Abstract/FREE Full Text
15. Ranganath C, Johnson MK, D'Esposito M. Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 2003;41:378–89

    CrossRefPubMedWeb of Science
16. ↵
    Wagner AD, Pare-Blagoev EJ, Clark J, et al. Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron 2001;31:329–38

    CrossRefPubMedWeb of Science
17. ↵
    Mandzia JL, McAndrews MP, Grady CL, et al. Neural correlates of incidental memory in mild cognitive impairment: an fMRI study. Neurobiol Aging 2007 Oct 24. [Epub ahead of print]
18. ↵
    Rombouts SA, Barkhof F, Van Meel CS, et al. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;73:665–71

    Abstract/FREE Full Text
19. Goekoop R, Rombouts SA, Jonker C, et al. Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 2004;23:1450–59

    CrossRefPubMedWeb of Science
20. ↵
    Saykin AJ, Wishart HA, Rabin LA, et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004;127:1574–83

    Abstract/FREE Full Text
21. Bentley P, Driver J, Dolan RJ. Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain 2008;131:409–24

    Abstract/FREE Full Text
22. ↵
    Shanks MF, McGeown WJ, Forbes-McKay KE, et al. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. Magn Reson Imaging 2007;25:848–59

    CrossRefPubMedWeb of Science
23. ↵
    Leyhe T, Stransky E, Eschweiler GW, et al. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2008;258:124–28

    CrossRefPubMed
24. ↵
    Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 2004;11:43–49

    Abstract/FREE Full Text
25. ↵
    Matthews B, Siemers ER, Mozley PD. Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer disease. Am J Geriatr Psychiatry 2003;11:146–59

    CrossRefPubMed
26. ↵
    Tune L, Tiseo PJ, Ieni J, et al. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. Am J Geriatr Psychiatry 2003;11:169–77

    CrossRefPubMedWeb of Science
27. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease: The Tacrine Study Group. JAMA 1994;271:985–91

    CrossRefPubMedWeb of Science
28. Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease: Donepezil Study Group. Neurology 1998;50:136–45

    Abstract/FREE Full Text
29. ↵
    Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD: The Galantamine USA-10 Study Group. Neurology 2000;54:2269–76

    Abstract/FREE Full Text
30. ↵
    Miller MB, Van Horn JD, Wolford GL, et al. Extensive individual differences in brain activations associated with episodic retrieval are reliable over time. J Cogn Neurosci 2002;14:1200–14

    CrossRefPubMedWeb of Science
31. ↵
    Kahn I, Davachi L, Wagner AD. Functional-neuroanatomic correlates of recollection: implications for models of recognition memory. J Neurosci 2004;24:4172–80

    Abstract/FREE Full Text
32. Sperling RA, Bates JF, Cocchiarella AJ, et al. Encoding novel face-name associations: a functional MRI study. Hum Brain Mapp 2001;14:129–39

    CrossRefPubMedWeb of Science
33. Leube DT, Erb M, Grodd W, et al. Successful episodic memory retrieval of newly learned faces activates a left fronto-parietal network. Brain Res Cogn Brain Res 2003;18:97–101

    CrossRefPubMed
34. ↵
    Grady CL, McIntosh AR, Bookstein F, et al. Age-related changes in regional cerebral blood flow during working memory for faces. Neuroimage 1998;8:409–25

    CrossRefPubMedWeb of Science